Synthetic Biologics, Inc. Gains 99.96%
Tue, Jan 05, 2021 at 05:32 PM
Synthetic Biologics, Inc. (SYN:NYSEMKT) rocketted at $1, representing a gain of 100%. On Fri 01 Jan 21, SYN:NYSEMKT touched a New 2-Week Intraday High of $0.43. The stock got featured on our News Catalysts scanner on Tue 22 Dec 20 at 07:18 AM in the 'BIOTECH' category. From Mon 21 Dec 20, the stock recorded 75.00% Up Days and 22.22% Green Days
The stock spiked on Thu 30 Jul 20 at $0.75 with a volume of 8M+.
About Synthetic Biologics, Inc. (SYN:NYSEMKT)
Synthetic Biologics Inc is a late-stage biotechnology company focused on developing gut microbiome therapeutics. It is also developing monoclonal antibody therapies for the treatment of pertussis.
Top 10 Gainers:
- RSVA (RSVA:NASDAQ), 865.52%
- Synthetic Biologics, Inc. (SYN:NYSEMKT), 99.96%
- Naked Brand Group Limited (NAKD:NASDAQ), 89.25%
- Mexco Energy Corporation (MXC:NYSEMKT), 85.28%
- The Peck Company Holdings, Inc. (PECK:NASDAQ), 70.08%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 65.5%
- Brickell Biotech, Inc. (BBI:NASDAQ), 48.55%
- Castor Maritime Inc. (CTRM:NASDAQ), 40.78%
- Zosano Pharma Corporation (ZSAN:NASDAQ), 38.26%
- Atomera Incorporated (ATOM:NASDAQ), 37.23%